Kiltearn Partners LLP Buys 345,471 CVS Health Shares
Kiltearn Partners LLP increased its stake in CVS Health by buying 345,471 shares worth about $35.74M, according to a Q2 13F filing. Wellington Management also expanded ownership. CVS reported quarterly EPS of $2.58, beating the $1.87 consensus, and several banks raised price targets while keeping buy or overweight views.